The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
Open accessAbstract
HDL is a major atheroprotective factor, but the mechanisms underlying this effect are still obscure. HDL binding to scavenger receptor-BI has been shown to activate eNOS, although the responsible HDL entities and signaling pathways have remained enigmatic. Here we show that HDL stimulates NO release in human endothelial cells and induces vasodilation in isolated aortae via intracellular Ca2+ mobilization and Akt-mediated eNOS phosphorylation. The vasoactive effects of HDL could be mimicked by three lysophospholipids present in HDL: sphingosylphosphorylcholine (SPC), sphingosine-1-phosphate (S1P), and lysosulfatide (LSF). All three elevated intracellular Ca2+ concentration and activated Akt and eNOS, which resulted in NO release and vasodilation. Deficiency of the lysophospholipid receptor S1P3 (also known as LPB3 and EDG3) abolished the vasodilatory effects of SPC, S1P, and LSF and reduced the effect of HDL by approximately 60%. In endothelial cells from S1P3-deficient mice, Akt phosphorylation and Ca2+ increase in response to HDL and lysophospholipids were severely reduced. In vivo, intra-arterial administration of HDL or lysophospholipids lowered mean arterial blood pressure in rats. In conclusion, we identify HDL as a carrier of bioactive lysophospholipids that regulate vascular tone via S1P3-mediated NO release. This mechanism may contribute to the vasoactive effect of HDL and represent a novel aspect of its antiatherogenic function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591 · cited 9×
“To test whether G protein– coupled receptor signaling by HDL and HDL-associated lysophospholipids is involved in their effects on NO generation and vasodilation, we preincubated HUVECs with pertussis toxin (PTX), an irreversible Gi activation blocker, prior to stimulation with HDL, SPC, S1P, and LSF. PTX (100 ng/ml) a…”
BackgroundInfluentialRegulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Lee, M.-J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I., & Hla, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81661-x · Cited by 1,013
Michiels, C. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10333 · Cited by 773
Lysophospholipid Receptors: Signaling and Biology
Ishii, I., Fukushima, N., Ye, X., & Chun, J. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073731 · Cited by 771
Self-citationYuhanna, I. S., Zhu, Y., Cox, B. E., Hahner, L. D., Osborne-Lawrence, S., Lu, P., Marcel, Y. L., Anderson, R. G. W., Mendelsohn, M. E., Hobbs, H. H., et al. (2001) · Nature Medicine · doi:10.1038/89986 · Cited by 742
Zachary, I. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00268-6 · Cited by 662
Nitric Oxide Insufficiency, Platelet Activation, and Arterial Thrombosis
Loscalzo, J. (2001) · Circulation Research · doi:10.1161/hh0801.089861 · Cited by 612
HDL and arteriosclerosis: beyond reverse cholesterol transport
Nofer, J.-R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., & Eckardstein, A. V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 595
Self-citationHaynes, M. P., Sinha, D., Russell, K. S., Collinge, M., Fulton, D., Morales-Ruiz, M., Sessa, W. C., & Bender, J. R. (2000) · Circulation Research · doi:10.1161/01.res.87.8.677 · Cited by 575
Estrogen Modulation of Endothelial Nitric Oxide Synthase
Chambliss, K. L., & Shaul, P. W. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0045 · Cited by 569
The Akt kinase signals directly to endothelial nitric oxide synthase
Michell, B. J., Griffiths, J. E., Mitchelhill, K. I., Rodriguez-Crespo, I., Tiganis, T., Bozinovski, S., de Montellano, P. R. O., Kemp, B. E., & Pearson, R. B. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80371-6 · Cited by 481
International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature
Chun, J., Goetzl, E. J., Hla, T., Igarashi, Y., Lynch, K. R., Moolenaar, W., Pyne, S., & Tigyi, G. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.265 · Cited by 464
Self-citationBoo, Y. C., Sorescu, G., Boyd, N., Shiojima, I., Walsh, K., Du, J., & Jo, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108789200 · Cited by 446
High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men
Spieker, L. E., Sudano, I., Hürlimann, D., Lerch, P. G., Lang, M. G., Binggeli, C., Corti, R., Ruschitzka, F., Lüscher, T. F., & Noll, G. (2002) · Circulation · doi:10.1161/01.cir.0000013424.28206.8f · Cited by 438
Mineo, C., Yuhanna, I. S., Quon, M. J., & Shaul, P. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211394200 · Cited by 390
Nofer, J.-R., Levkau, B., Wolinska, I., Junker, R., Fobker, M., von Eckardstein, A., Seedorf, U., & Assmann, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103782200 · Cited by 359
Self-citationFukushima, N., Ishii, I., Contos, J. J., Weiner, J. A., & Chun, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.507 · Cited by 322
Self-citationHaynes, M. P., Li, L., Sinha, D., Russell, K. S., Hisamoto, K., Baron, R., Collinge, M., Sessa, W. C., & Bender, J. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210828200 · Cited by 304
The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease
Cohen, R. A. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80002-7 · Cited by 286
Plasma Membrane Estrogen Receptors Are Coupled to Endothelial Nitric-oxide Synthase through Gαi
Wyckoff, M. H., Chambliss, K. L., Mineo, C., Yuhanna, I. S., Mendelsohn, M. E., Mumby, S. M., & Shaul, P. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100312200 · Cited by 282
Morales-Ruiz, M., Lee, M.-J., Zöllner, S., Gratton, J.-P., Scotland, R., Shiojima, I., Walsh, K., Hla, T., & Sessa, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009993200 · Cited by 276
Ishii, I., Friedman, B., Ye, X., Kawamura, S., McGiffert, C., Contos, J. J. A., Kingsbury, M. A., Zhang, G., Brown, J. H., & Chun, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104441200 · Cited by 272
Self-citationKimura, T., Sato, K., Kuwabara, A., Tomura, H., Ishiwara, M., Kobayashi, I., Ui, M., & Okajima, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104353200 · Cited by 261
Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins.
Fleisher, L. N., Tall, A. R., Witte, L. D., Miller, R. W., & Cannon, P. J. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34477-6 · Cited by 252
Sphingosine 1-Phosphate and Activation of Endothelial Nitric-oxide Synthase
Igarashi, J., Bernier, S. G., & Michel, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008375200 · Cited by 248
Ishii, I., Ye, X., Friedman, B., Kawamura, S., Contos, J. J. A., Kingsbury, M. A., Yang, A. H., Zhang, G., Brown, J. H., & Chun, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200137200 · Cited by 244
Self-citationLysophospholipid receptor nomenclature
Lynch, K. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00138-5 · Cited by 222
High-Density Lipoproteins and Endothelial Function
O’Connell, B. J., & Genest, J. (2001) · Circulation · doi:10.1161/hc3901.096667 · Cited by 217
Xu, Y. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00140-3 · Cited by 212
Diadenosine phosphates and the physiological control of blood pressure
Schlüter, H., Offers, E., Brüggemann, G., van der Giet, M., Tepel, M., Nordhoff, E., Karas, M., Spieker, C., Witzel, H., & Zidek, W. (1994) · Nature · doi:10.1038/367186a0 · Cited by 207
Self-citationKwon, Y.-G., Min, J.-K., Kim, K.-M., Lee, D.-J., Billiar, T. R., & Kim, Y.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011449200 · Cited by 206
Tanimoto, T., Jin, Z.-G., & Berk, B. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204764200 · Cited by 188
Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P
OHMORI, T., YATOMI, Y., OSADA, M., KAZAMA, F., TAKAFUTA, T., IKEDA, H., & OZAKI, Y. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00260-8 · Cited by 180
Regression or Progression: Dependency on Vascular Nitric Oxide
Candipan, R. C., Wang, B.-Y., Buitrago, R., Tsao, P. S., & Cooke, J. P. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.1.44 · Cited by 180
Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology
Levade, T., Augé, N., Veldman, R. J., Cuvillier, O., Nègre-Salvayre, A., & Salvayre, R. (2001) · Circulation Research · doi:10.1161/hh2301.100350 · Cited by 169
Harrison, D. G., & Ohara, Y. (1995) · The American Journal of Cardiology · doi:10.1016/0002-9149(95)80018-n · Cited by 163
Li, X.-A., Titlow, W. B., Jackson, B. A., Giltiay, N., Nikolova-Karakashian, M., Uittenbogaard, A., & Smart, E. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110985200 · Cited by 162
Gong, M. C., Wilson, M. E., Kelly, T. H., Su, W., Dressman, J. L., Kincer, J. F., Matveev, S. V., Guo, L., Guerin, T. M., Li, X., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16777 · Cited by 152
Zhang, G., Contos, J. J. A., Weiner, J. A., Fukushima, N., & Chun, J. J. M. (1999) · Gene · doi:10.1016/s0378-1119(98)00589-7 · Cited by 146
Self-citationSphingosylphosphorylcholine—biological functions and mechanisms of action
zu Heringdorf, D. M. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00154-3 · Cited by 135
Sphingosine 1-phosphate and control of vascular tone
Dantas, A. P., Igarashi, J., & Michel, T. M. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01089.2002 · Cited by 120
S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate
Salomone, S., Yoshimura, S.-I., Reuter, U., Foley, M., Thomas, S. S., Moskowitz, M. A., & Waeber, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01731-x · Cited by 119
In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice
Yang, A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00172-5 · Cited by 108
McGiffert, C., Contos, J. J. A., Friedman, B., & Chun, J. J. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03404-x · Cited by 106
Self-citationEndothelial cell functions.¶Relationship to atherogenesis
Toborek, M. J., & Kaiser, S. (1999) · Basic Research in Cardiology · doi:10.1007/s003950050156 · Cited by 101
Nofer, J., Fobker, M., Höbbel, G., Voß, R., Wolinska, I., Tepel, M., Zidek, W., Junker, R., Seedorf, U., von Eckardstein, A., et al. (2000) · Biochemistry · doi:10.1021/bi001162a · Cited by 71
Self-citationRuwisch, L., Schäfer-Korting, M., & Kleuser, B. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000365 · Cited by 68
Self-citationSugimoto, K., Fujii, S., Takemasa, T., & Yamashita, K. (2000) · Histochemistry and Cell Biology · doi:10.1007/s004180000151 · Cited by 50
Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology
Tamama, K., & Okajima, F. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00004 · Cited by 49
Banno, Y., Takuwa, Y., Yamada, M., Takuwa, N., Ohguchi, K., Hara, A., & Nozawa, Y. (2003) · Biochemical Journal · doi:10.1042/bj20021368 · Cited by 41
Cited by
Nathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
“Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
Takabe, K., Paugh, S. W., Milstien, S., & Spiegel, S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07113 · Cited by 718
Endothelial and Antithrombotic Actions of HDL
Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 655
Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647
Metadata
- Authors
- Nofer, J.-R., van der Giet, M., Tölle, M., Wolinska, I., von Wnuck Lipinski, K., Baba, H. A., Tietge, U. J., Gödecke, A., Ishii, I., Kleuser, B., Schäfers, M., Fobker, M., Zidek, W., Assmann, G., Chun, J., & Levkau, B.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-02-15
- Volume
- 113
- Issue
- 4
- Pages
- 569-581
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2138137064
- Cited by
- 698
- References
- 53
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.